MoneyWorks4Me

The Sales for the quarter ended September 2024 of Rs. 66963.00 millions rose by 38.39% from Rs. 48387.00 millions.Handsome Net Profit growth of 57.81% reported above the corresponding previous quarter figure of Rs. 18821.00 millions to Rs. 11926.00 millions.OP of the company witnessed a marginal growth to 29292.00 millions from 18522.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 66963.00 48387.00 38.39 125375.00 102760.00 22.01 194838.00 169625.00 14.86
Other Income 2076.00 2231.00 -6.95 4254.00 4567.00 -6.85 8623.00 5913.00 45.83
PBIDT 29292.00 18522.00 58.15 51000.00 43135.00 18.23 67887.00 48061.00 41.25
Interest 284.00 58.00 389.66 355.00 103.00 244.66 218.00 169.00 28.99
PBDT 29008.00 18464.00 57.11 50645.00 43032.00 17.69 67669.00 47892.00 41.29
Depreciation 2600.00 2458.00 5.78 5098.00 4830.00 5.55 9756.00 9232.00 5.68
PBT 26408.00 16006.00 64.99 45547.00 38202.00 19.23 57913.00 38660.00 49.80
TAX 7587.00 4080.00 85.96 12554.00 9882.00 27.04 14493.00 12532.00 15.65
Deferred Tax 554.00 120.00 361.67 855.00 535.00 59.81 875.00 3891.00 -77.51
PAT 18821.00 11926.00 57.81 32993.00 28320.00 16.50 43420.00 26128.00 66.18
Equity 834.00 834.00 0.00 834.00 834.00 0.00 834.00 833.00 0.12
PBIDTM(%) 43.74 38.28 14.28 40.68 41.98 -3.09 34.84 28.33 22.97
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..